What are you searching for…

Happy Holidays!

21-12-2020

Happy Holidays!

We would like to wish you a Happy Holidays and a wonderful New Year.

We look forward to seeing you in 2021!

Astrazeneca&牛津大学

19-12-2020

Astrazeneca&牛津大学

AstraZeneca and The University of Oxford released results from its Phase 3 analysis of its COVID-19 vaccine candidate, AZD1222.

Drawn from two separate regimens, a half dose giving 90% efficacy and two full doses giving 62% efficacy, the pooled efficacy rate totalled 70%.Discover more.

免疫细胞和抗体

17-12-2020

免疫细胞和抗体

New research has shed light on the role of antibodies and immune cells in the protection against SARS-CoV-2.
The findings have important implications for the development of SARS-CoV-2 vaccines and immune based therapeutics.

Find out more!

Almac Sciences.

14-12-2020

Almac Sciences.

Almac Sciences.received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug, Remdesivir.

该药物是the first to receive approval of the FDA as a treatment for COVID-19.

Read more here!

合作

12-12-2020

合作

From aligning ourselves with industry leading experts, Baker has a strong understanding of the wider industry and the complex problems that our customers face.

Visit our collaboration page on the website for more information.

Take a look!

Alzheimer’s Research

10-12-2020

Alzheimer’s Research

Following on from last month’s Fact or Fiction focus on Neurodegenerative diseases, researchers at Case Western Reserve University School of Medicine identified a molecular pathway in Alzheimer’s disease.

The new discovery could lead to developments in therapeutics for the disease.

Find out more!

Dr. Ox Updates

09-12-2020

Dr. Ox Updates

Did you see the review Dr. Ox shared on the role of hypoxia inducible factor-1 in cancer stem cells?

前往Twitterand see the latest content from Baker’s Director of Scientific Applications.

Study of Aprotinin

08-12-2020

Study of Aprotinin

A recent study has shown that Aprotinin, a drug that is well known for reducing the risk of bleeding during surgery can stop the novel Coronavirus from entering and infecting host cells.

Discover more!

Johnson & Johnson’s Vaccine Candidate

07-12-2020

Johnson & Johnson’s Vaccine Candidate

约翰逊&约翰逊为其Janssen Covid-19疫苗候选人推出了第二阶段3次审判。
This time, they are looking to explore a 2-dose regimen.
Find out more!

Bioprocessing Technologies

06-12-2020

Bioprocessing Technologies

Researchers have said that biopharma firms have had to accelerate their adoption of new and innovative technologies since the COVID-19 pandemic began.

The development of SARS-CoV-2 vaccines and drugs combined have been major driving factors for these market changes.

Read more!

The story of Sir Peter Ratcliffe’s Nobel Prize for Physiology or Medicine 2019 – View On Demand Webinar!

01-12-2020

The story of Sir Peter Ratcliffe’s Nobel Prize for Physiology or Medicine 2019 – View On Demand Webinar!

View the first webinar of the series from Baker Ruskinn as Baker’s Director of Scientific Applications, Krista Rantanen Ph.D. presents Sir Peter Ratcliffe’s Nobel story.

Watch Now

Ask us a question? Get in touch

联系我们